CE vs OKUR · rev $10.28B vs P/E 72, $76.6M cap
Celanese Corporation (CE) versus OnKure Therapeutics, Inc. (OKUR) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
OnKure Therapeutics, Inc. (OKUR) is a biotechnology company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported OKUR revenue for 2024-12-31 was $0. Net income was -$52.7M. OKUR currently screens at market cap $76.6M and trailing P/E 71.8.
CE currently screens at market cap $5.92B. OKUR currently screens at market cap $76.6M and trailing P/E 71.8.
Not investment advice. Open the CE and OKUR stock pages for the full models.
Not investment advice.